Ticker: ESPR

Company: Esperion Therapeutics, Inc.

Person: Benjamin Halladay, officer

Transaction date: Sept. 17, 2025

Reporting date: Sept. 18, 2025

Average share price: 2.808

Sold 7046.0 shares for 19785.17